TGF-β signaling |
ALK5 |
Deubiquitination and stabilization of TβR-I by making a complex with SMAD7 and SMURF2 |
Enhances the activity of TGF-β signaling and promotes oncogenesis in glioblastoma |
[13] |
BMP signaling |
ALK3 |
Deubiquitination of type I BMP receptor ALK3 by interacting with BMP inhibitor SMAD6 |
Enhances BMP target gene transcription in mammalian cells, osteoblastic differentiation in mouse, and embryogenesis in Xenopus
|
[39] |
COP9 signalosome |
CRLs |
Deubiquitination and stabilization of CRL adaptor proteins and associated substrates |
Regulation of cullin activity |
[58] |
Regulation of multicellular development and secondary metabolism |
[59] |
Protects and stabilizes the components of CRLs for rearrangement and adaptation to altered cellular requirements |
[60] |
NF-κB signaling |
IκBα |
Deubiquitination and stabilization of IκBα |
Inhibition of NF-ĸB signaling and downstream gene expression |
[33] |
NF-κB p65 |
Inhibition of NF-κBp65 ubiquitination |
Induces cell proliferation and inhibition of cell apoptosis in multiple myeloma by activating NF-κB signaling |
[68] |
TAB2 and TAB3 |
Stabilization of TAB2 and TAB3 by inhibiting their proteolysis |
Potentiates TNFα- or IL-1β-induced NF-ĸB activation and downstream gene transcription |
[67] |
Wnt/β-catenin signaling |
APC |
Stabilization of APC in the β-catenin destruction complex |
Suppresses Wnt/β-catenin signaling and target gene expression |
[35] |
HECTD1 |
Deubiquitination and stabilization of HECTD1 |
Tumor suppression in a subset of glioblastoma by attenuating the canonical Wnt pathway |
[73] |
β-catenin |
Stabilization of β-catenin by inhibiting degradation |
Osteoblast differentiation and bone formation |
[74] |
p53 signaling |
MDM2 |
Deubiquitination and stabilization of MDM2 |
Downregulation of p53 along with its target genes and cancer cell survival |
[34] |
MDM2 via TIFAB |
Increases the deubiquitination and stabilization of MDM2, which is boosted by TIFAB |
Suppresses p53 activity in stressed and malignant hematopoietic cells |
[80] |
E6 |
Increases E6 protein stability |
Upregulation of E6 oncoproteins may facilitate cancer progression in HPV-infected cells |
[82] |
p53 |
Binding and stabilization of p53 |
TGF-β signaling-mediated stabilization of p53 through increased USP15 translation that suppresses the early stages of cancer progression |
[84] |
IGF signaling |
IRS-2 |
Binding to and antagonizing of IRS-2 ubiquitination |
Regulation of cancer cell progression by fine-tuning of IGF-induced growth-promoting activity |
[87] |
Immune signaling |
TRIM25 |
Deubiquitination and stabilization of TRIM25 |
Promotes antiviral innate immune responses |
[91] |
Nrf2–Keap1 signaling |
Keap1 |
Deubiquitination of Keap1 and enhancement of the Keap1–Cul3–E3 ligase complex stability |
Promotes Nrf2 protein degradation and reduces the Nrf2 target gene expression |
[38] |